ProtonDx
ProtonDx is dedicated to providing innovative diagnostic solutions for human and animal health, as well as life sciences. Their products, including the Dragonfly Molecular Diagnostic Platform and SmartLid extraction kits, TurboBeads (potentially the fastest magnetic beads on the market) are designed for rapid, truly portable, and accurate diagnostics, enhancing public health outcomes and supporting research initiatives. Fully automated, lab-on-a-chip, molecular diagnostic platform Lacewing is nearing completion and even greater innovation.
Industries
Nr. of Employees
small (1-50)
ProtonDx is currently seeking investment
ProtonDx is seeking a series-a investment in the range of 1m-5m
Products
Portable multiplex molecular diagnostic system (respiratory panel)
A portable, point-of-care molecular diagnostic system that uses rapid nucleic acid extraction and isothermal amplification with colorimetric readout to detect and differentiate multiple respiratory pathogens from a single swab in under 30 minutes. Intended for use by trained operators (not self-testing).
Bead-based RNA/DNA extraction kit (research use only)
A research-use-only nucleic acid extraction kit using magnetic superparamagnetic silica beads to deliver ultra-pure DNA/RNA in less than 10 minutes, compatible with multiple liquid sample types and designed to minimise plastic waste.
Dragonfly Malaria Diagnostic Panels
The Dragonfly platform is validated for malaria detection/screening by configuring the LyoLAMP panel for Plasmodium targets and integrating it with a finger-prick blood workflow suitable for field use. The assay design supports both pan-malaria detection and species-level differentiation within a single sample-to-result workflow, using a simplified extraction step compatible with low-resource deployment.
Dragonfly - Livestock and Production Infection Diagnostics - PRRSV, Swine Influenze
The Dragonfly PRRSV and Swine Influenza panels are being commercialized as a vehicle to identify the presence of two of the most devastating and common biosecurity risks to the pork industry. As a rapid, portable, molecular test that can be used on the farm or in a processing plant, Dragonfly can provide the identification of key pathogens in less than an hour versus the current practice of waiting a day or two for results. Development of a rapid Salmonella test, using an existing proprietary assay is underway. This platform can be adapted for many other pathogen targets.
Portable multiplex molecular diagnostic system (respiratory panel)
A portable, point-of-care molecular diagnostic system that uses rapid nucleic acid extraction and isothermal amplification with colorimetric readout to detect and differentiate multiple respiratory pathogens from a single swab in under 30 minutes. Intended for use by trained operators (not self-testing).
Bead-based RNA/DNA extraction kit (research use only)
A research-use-only nucleic acid extraction kit using magnetic superparamagnetic silica beads to deliver ultra-pure DNA/RNA in less than 10 minutes, compatible with multiple liquid sample types and designed to minimise plastic waste.
Dragonfly Malaria Diagnostic Panels
The Dragonfly platform is validated for malaria detection/screening by configuring the LyoLAMP panel for Plasmodium targets and integrating it with a finger-prick blood workflow suitable for field use. The assay design supports both pan-malaria detection and species-level differentiation within a single sample-to-result workflow, using a simplified extraction step compatible with low-resource deployment.
Dragonfly - Livestock and Production Infection Diagnostics - PRRSV, Swine Influenze
The Dragonfly PRRSV and Swine Influenza panels are being commercialized as a vehicle to identify the presence of two of the most devastating and common biosecurity risks to the pork industry. As a rapid, portable, molecular test that can be used on the farm or in a processing plant, Dragonfly can provide the identification of key pathogens in less than an hour versus the current practice of waiting a day or two for results. Development of a rapid Salmonella test, using an existing proprietary assay is underway. This platform can be adapted for many other pathogen targets.
Expertise Areas
- Point-of-care molecular diagnostics
- Nucleic acid extraction workflows
- Multiplex respiratory pathogen testing
- Assay development for human and animal health
Key Technologies
- Isothermal LAMP amplification
- Colorimetric readout for nucleic acid amplification
- Magnetic bead-based nucleic acid extraction (superparamagnetic silica beads)
- Lab-on-chip cartridge architecture
Key People
News & Updates
Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle the spread of disease.
Infectious disease specialist Major Scott Pallett tested the ProtonDx Dragonfly in extreme conditions 600 km north of the Arctic Circle.
Bob Enck has been appointed as CEO to strengthen leadership and focus on commercial growth in diagnostics.
Dr. Szostak-Lipowicz discussed how ProtonDx's work can help bridge healthcare gaps in Africa at a UN panel.
Dr. Jesus Rodriguez Manzano discusses the current threat of a ‘tripledemic’ and the importance of rapid diagnostics.
Dr. Jesus Rodriguez-Manzano emphasizes the need for better diagnostics to tackle antimicrobial resistance.
Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle the spread of disease.
Infectious disease specialist Major Scott Pallett tested the ProtonDx Dragonfly in extreme conditions 600 km north of the Arctic Circle.
Bob Enck has been appointed as CEO to strengthen leadership and focus on commercial growth in diagnostics.
Dr. Szostak-Lipowicz discussed how ProtonDx's work can help bridge healthcare gaps in Africa at a UN panel.
Dr. Jesus Rodriguez Manzano discusses the current threat of a ‘tripledemic’ and the importance of rapid diagnostics.
Dr. Jesus Rodriguez-Manzano emphasizes the need for better diagnostics to tackle antimicrobial resistance.